Hims & Hers just posted strong earnings. The stock still got punched in the face. That’s not a contradiction — it’s the whole story. HIMS is one of the market’s most polarizing growth names right now. Bulls see a profitable DTC healthcare machine with a loyal subscriber base and a massive runway. Bears see a…